Literature DB >> 8382293

WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present.

A G Mosser1, R R Rueckert.   

Abstract

Twenty-two spontaneous mutants of the Sabin strain of poliovirus type 3 were selected for drug resistance by plating on HeLa cell monolayers in the presence of WIN 51711, an uncoating inhibitor. When replated in the presence and absence of drug, two classes of mutants were observed; mutants displayed either a drug-dependent or a non-drug-dependent phenotype, in the proportion 14:8. Non-drug-dependent mutants plaqued with equal efficiency in the presence or absence of drug. By contrast, drug-dependent mutants made no plaques in the absence of drug, except for revertants. In single-step growth curve experiments, however, drug-dependent mutants grew as well in the absence of drug as in its presence. This paradoxical behavior of dependent mutants was traced to extreme thermolability at 37 degrees C (12- to 30-s half-life) in the absence of drug. Thermolability was exhibited only after the virus was released from the cell, implying the presence of a cell-associated protective factor, possibly pocket factor. Thus, in the absence of a thermostabilizing drug, drug-dependent mutants decayed too rapidly after release to permit spread in the plaque assay. The thermodecay product was shown to consist of 135S particles lacking VP4.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382293      PMCID: PMC237490     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Inhibition of poliovirus uncoating by disoxaril (WIN 51711).

Authors:  H Zeichhardt; M J Otto; M A McKinlay; P Willingmann; K O Habermehl
Journal:  Virology       Date:  1987-09       Impact factor: 3.616

2.  Stabilization of poliovirus against heat inactivation.

Authors:  B L Dorval; M Chow; A M Klibanov
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

3.  Evidence for the direct involvement of the rhinovirus canyon in receptor binding.

Authors:  R J Colonno; J H Condra; S Mizutani; P L Callahan; M E Davies; M A Murcko
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

5.  Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.

Authors:  M P Fox; M J Otto; M A McKinlay
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

6.  The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.

Authors:  T J Smith; M J Kremer; M Luo; G Vriend; E Arnold; G Kamer; M G Rossmann; M A McKinlay; G D Diana; M J Otto
Journal:  Science       Date:  1986-09-19       Impact factor: 47.728

7.  Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.

Authors:  J Badger; I Minor; M J Kremer; M A Oliveira; T J Smith; J P Griffith; D M Guerin; S Krishnaswamy; M Luo; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

8.  WIN 51711, a new systematically active broad-spectrum antipicornavirus agent.

Authors:  M A McKinlay
Journal:  J Antimicrob Chemother       Date:  1985-09       Impact factor: 5.790

9.  Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors.

Authors:  D C Pevear; M J Fancher; P J Felock; M G Rossmann; M S Miller; G Diana; A M Treasurywala; M A McKinlay; F J Dutko
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.

Authors:  M J Otto; M P Fox; M J Fancher; M F Kuhrt; G D Diana; M A McKinlay
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

View more
  28 in total

1.  An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.

Authors:  A W Dove; V R Racaniello
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus.

Authors:  D M Belnap; D J Filman; B L Trus; N Cheng; F P Booy; J F Conway; S Curry; C N Hiremath; S K Tsang; A C Steven; J M Hogle
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst.

Authors:  S K Tsang; B M McDermott; V R Racaniello; J M Hogle
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 4.  Poliovirus cell entry: common structural themes in viral cell entry pathways.

Authors:  James M Hogle
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

5.  Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase.

Authors:  Jamie J Arnold; Marco Vignuzzi; Jeffrey K Stone; Raul Andino; Craig E Cameron
Journal:  J Biol Chem       Date:  2005-05-05       Impact factor: 5.157

6.  Characterization of poliovirus variants selected for resistance to the antiviral compound V-073.

Authors:  Hong-Mei Liu; Jason A Roberts; Deborah Moore; Barbara Anderson; Mark A Pallansch; Daniel C Pevear; Marc S Collett; M Steven Oberste
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

7.  Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors.

Authors:  S Liao; V Racaniello
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Molecular dynamics simulations of human rhinovirus and an antiviral compound.

Authors:  B Speelman; B R Brooks; C B Post
Journal:  Biophys J       Date:  2001-01       Impact factor: 4.033

9.  Long-distance correlations of rhinovirus capsid dynamics contribute to uncoating and antiviral activity.

Authors:  Amitava Roy; Carol Beth Post
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-21       Impact factor: 11.205

10.  Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins.

Authors:  C Aberham; S Weber; W Phares
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.